Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Diagnostic Codes

ICD-10 Code I43: Cardiomyopathy due to other conditions

Key Takeaways

Key Takeaways

ICD-10 Code I43 is a billable 2026 ICD-10-CM diagnosis code for cardiomyopathy arising as a direct manifestation of another underlying disease, not as a primary cardiac condition.

I43 carries a mandatory Code First instruction – the underlying etiology (such as amyloidosis or sarcoidosis) must always be sequenced as the principal diagnosis before I43.

Common triggering conditions include amyloidosis, sarcoidosis, acromegaly, glycogen storage disease, Chagas disease, diphtheria, and thyrotoxicosis – each requires its own primary code.

Pabau’s claims management software helps cardiology and general medicine practices flag etiology-first sequencing requirements at the point of documentation, reducing claim denials.

Secondary cardiomyopathy is one of the most sequencing-sensitive diagnoses in cardiology coding. When the heart muscle deteriorates because of another systemic disease, the coding rules change entirely: the underlying condition takes the lead, and the cardiomyopathy code follows. Get that order wrong and the claim fails. ICD-10 diagnostic coding for manifestation codes like I43 follows a strict etiology-manifestation convention that many practices encounter for the first time when a cardiologist documents secondary cardiomyopathy in a patient with amyloidosis or sarcoidosis.

This guide covers the clinical definition of ICD-10 Code I43, its mandatory Code First sequencing rule, inclusion terms, documentation requirements, related codes, and billing considerations for 2026. Whether you code for a cardiology group, a general medicine clinic, or a specialist practice treating systemic diseases with cardiac involvement, these rules apply every time I43 appears in the chart.

ICD-10 Code I43: definition and clinical classification

ICD-10 Code I43 describes cardiomyopathy that develops as a direct manifestation of another disease classified elsewhere in ICD-10-CM. The heart muscle weakens or dysfunctions not because of a primary cardiac condition, but because of systemic disease affecting the myocardium as a secondary consequence. This distinguishes it clearly from I42, which covers primary (idiopathic) cardiomyopathy where no underlying systemic cause is identified.

Clinically, I43 applies when a cardiologist or internist documents cardiac muscle involvement in a patient already diagnosed with a systemic illness. The cardiomyopathy is the manifestation; the systemic illness is the etiology. Both must be coded, and the etiology code always comes first.

Classification hierarchy

I43 sits within ICD-10-CM Chapter 9 (Diseases of the Circulatory System, codes I00-I99), under the subcategory I30-I5A (Other Forms of Heart Disease). It is a flat, single-level code in ICD-10-CM for the United States. No valid subcategories (such as I43.0 or I43.8) exist within the U.S. ICD-10-CM system, even though some WHO ICD-10 editions include subcategories – practices using ICD-10-CM must use I43 without any extension.

CodeDescriptionType2026 Status
I43Cardiomyopathy in diseases classified elsewhereManifestation (secondary)Billable / Valid
I42Cardiomyopathy (primary/unspecified)PrimaryBillable / Valid
I42.0Dilated cardiomyopathyPrimary subtypeBillable / Valid
I42.5Other restrictive cardiomyopathyPrimary subtypeBillable / Valid

I43 is confirmed billable for fiscal year 2026 by the CDC/NCHS ICD-10-CM web tool and multiple authoritative coding references. The ICD-9-CM approximate equivalent is 425.8 (Cardiomyopathy in other diseases classified elsewhere), confirmed via the standard crosswalk.

Understanding the Code First instruction

The single most important rule for I43 is the Code First instruction. This is not optional. Under the etiology-manifestation convention established by the CMS ICD-10-CM Official Guidelines for Coding and Reporting, when a code carries a Code First note, the underlying disease code must appear as the first-listed (principal) diagnosis. I43 then follows as an additional code.

Reversing the sequence – placing I43 first and the underlying condition second – misrepresents the clinical picture and will typically trigger a denial or recode request. This sequencing rule also affects DRG assignment and risk adjustment calculations, which directly affects reimbursement.

How the etiology-manifestation convention works in practice

The etiology-manifestation convention in ICD-10 applies whenever one code describes the root cause and another describes a body system complication. For I43, the convention requires this exact sequencing pattern:

  1. First code: the underlying systemic disease (e.g., E85.9 for amyloidosis, D86.89 for sarcoidosis with cardiac involvement)
  2. Second code: I43 (Cardiomyopathy in diseases classified elsewhere)
  3. Additional codes as needed: any associated heart failure codes (I50.-), arrhythmias, or other cardiac manifestations

The ICD-10-CM tabular list entry for I43 explicitly instructs coders to code first the underlying disease. This instruction appears directly in the code’s tabular notes and applies universally regardless of payer, setting, or documentation style.

Pro Tip

Flag I43 encounters in your EHR workflow with an automatic prompt that checks whether an etiology code has been listed before I43. Practices using smart coding alerts catch sequencing errors before claim submission rather than after a denial – typically saving two to three weeks of rework per affected claim.

Inclusion terms and synonyms

The ICD-10-CM tabular list for I43 includes several inclusion terms that guide coders when the clinical documentation uses alternate terminology. Knowing these synonyms helps coders avoid defaulting to I42 (primary cardiomyopathy) when the chart actually describes a secondary manifestation.

  • Acromegalic cardiomyopathy – cardiomyopathy arising in the context of acromegaly (excess growth hormone, typically coded to E22.0)
  • Cardiac amyloidosis – myocardial involvement in systemic amyloidosis (E85.-)
  • Cardiomyopathy in sarcoidosis – cardiac involvement in sarcoid disease (D86.-)
  • Cardiomyopathy in glycogen storage disease – cardiac manifestation of metabolic storage disorders (E74.-)
  • Cardiomyopathy in thyrotoxicosis – thyroid-driven cardiomyopathy (E05.-)
  • Cardiomyopathy in Chagas disease – cardiac form of American trypanosomiasis (B57.-)
  • Cardiomyopathy in diphtheria – myocardial involvement in diphtheria infection (A36.-)

When documentation uses any of these terms, I43 is the correct manifestation code – provided the underlying disease is also coded and sequenced first. Cross-reference the WHO ICD-10 browser for the international classification context, and verify current U.S.-specific inclusion terms against the official CMS tabular list for each coding year.

One nuance worth noting: Chagas disease cardiomyopathy has its own specific code (B57.2) that includes the cardiac manifestation. Review current tabular guidance before deciding whether I43 or B57.2 better captures the clinical situation in a Chagas case – coding conventions evolve annually.

ICD-10 Code I43 documentation and coding accuracy

Claim success with ICD-10 Code I43 depends on documentation that clearly establishes the causal relationship between the underlying systemic disease and the cardiomyopathy. Without that explicit link in the clinical record, a coder cannot assign I43 with confidence, and a payer auditor will challenge the code.

What the record must establish

The attending physician or cardiologist must document three things clearly:

  1. The underlying diagnosis – the systemic disease causing the cardiac involvement, named explicitly (not implied)
  2. The causal relationship – a statement linking the underlying disease to the cardiomyopathy (e.g., “cardiomyopathy secondary to amyloidosis” or “cardiac involvement in sarcoidosis”)
  3. Cardiac functional status – the degree of cardiac impairment, arrhythmia burden, or heart failure stage, because associated codes (I50.-, I49.-) often need to be added alongside I43

Without the explicit causal language, a coder may only be able to code the underlying disease and the cardiomyopathy separately – losing the diagnostic precision that I43 provides and potentially affecting DRG grouping. Practices with robust clinical documentation tools that support structured note templates for cardiology encounters see fewer queries back to the physician for clarification.

Comprehensive EMR & patient record management
Comprehensive EMR & patient record management

Common documentation errors

Three errors account for most I43 coding problems in practice:

  • Reversed sequencing: I43 listed as the principal diagnosis with the underlying disease as secondary. Always sequence the etiology first.
  • Missing causal language: the record lists both diagnoses but does not state that one caused the other. Coders cannot assume causality – it must be documented.
  • Using I43 for primary cardiomyopathy: when no systemic cause is documented, I42 is correct. I43 requires a clearly identified underlying disease.

The AAPC Codify ICD-10-CM lookup and the CDC/NCHS tabular list both display the Code First note prominently for I43, making it straightforward to catch during a coding audit. Supporting EHR integration workflows that surface these notes at the point of coding further reduces sequencing errors.

Pro Tip

Run a quarterly audit on all claims submitted with I43 as the first-listed code. Any claim with I43 in position 1 is a sequencing error by definition. Pull those encounters, identify the underlying disease in the chart, and correct the claim before the denial cycle begins.

Billing for secondary cardiomyopathy involves more than getting I43 right. The code rarely stands alone – it almost always appears alongside the etiology code and frequently alongside heart failure codes, arrhythmia codes, or both. Each additional code must be supported by documentation and sequenced correctly.

Commonly paired codes

CodeDescriptionRelationship to I43
E85.9Amyloidosis, unspecifiedCommon etiology, sequenced before I43
D86.89Sarcoidosis of other sites (cardiac)Common etiology, sequenced before I43
E22.0Acromegaly and pituitary gigantismEtiology for acromegalic cardiomyopathy, sequenced before I43
E05.90Thyrotoxicosis, unspecified, without thyrotoxic crisisEtiology for thyrotoxic cardiomyopathy, sequenced before I43
I50.9Heart failure, unspecifiedAssociated manifestation, coded after I43
I49.9Cardiac arrhythmia, unspecifiedAssociated manifestation, coded after I43
I42Cardiomyopathy (primary)Use instead of I43 when no systemic cause is identified

For practices managing cardiology billing alongside complex chronic disease coding, Pabau’s claims management software supports multi-code claim assembly, helping ensure that etiology codes, manifestation codes, and associated condition codes are all captured and sequenced correctly before submission. This is particularly useful for practices treating high volumes of patients with amyloidosis or inflammatory systemic diseases where I43 appears frequently.

Automate claims through Healthcode
Automate claims through Healthcode

ICD-9-CM crosswalk

For practices that maintain legacy records or work with payers still reconciling older claims, the standard ICD-9-CM approximate equivalent for I43 is 425.8 (Cardiomyopathy in other diseases classified elsewhere). This crosswalk is confirmed via the icd10data.com conversion tool and is consistent across standard crosswalk tables. Note that “approximate” means functional equivalence, not exact clinical mapping – the ICD-10-CM system provides greater specificity than the ICD-9 equivalent allowed.

Practices tracking cardiology-related ICD-10 codes for cardiovascular diagnoses alongside I43 should also review how secondary cardiac codes interact with DRG assignment in their inpatient case mix, since the sequencing of I43 relative to other cardiac codes affects which DRG the encounter falls into.

Payer and reimbursement considerations

Most commercial payers and Medicare follow CMS sequencing guidelines. Correct etiology-first sequencing is therefore a universal requirement, not a payer-specific one. However, reimbursement rates for encounters coded with I43 vary depending on the underlying condition, the associated manifestations, and whether the encounter is inpatient or outpatient.

Outpatient encounters typically bill I43 alongside the evaluation and management CPT code for the visit. Inpatient encounters will have I43 influence DRG grouping as a secondary diagnosis under the principal systemic disease. Prior authorization requirements for diagnostic workups (echocardiography, cardiac MRI) in secondary cardiomyopathy vary by payer – verify authorization requirements through the CMS ICD-10 coding resources and individual payer portals before ordering high-cost cardiac imaging.

Practices can also benefit from reviewing HIPAA-compliant clinic software standards when transmitting multi-code claims electronically, especially when systemic disease codes and cardiac manifestation codes cross multiple billing specialties within the same claim. Maintaining patient data security across integrated billing and clinical documentation systems is essential when sensitive systemic diagnoses (such as HIV-related cardiomyopathy) appear alongside I43.

Reduce claim denials from sequencing errors

Pabau helps cardiology and general medicine practices capture etiology-manifestation coding requirements at the point of documentation – so I43 and its underlying disease codes always sequence correctly before your claim leaves the practice.

Pabau practice management dashboard

I43 vs. I42: when to use each code

The I43 vs. I42 distinction is one of the most practical questions coders face in cardiology. The decision comes down to whether the documentation establishes a specific underlying systemic cause:

  • Use I43 when the physician documents a named underlying disease causing the cardiomyopathy and establishes a causal relationship between them.
  • Use I42 (with appropriate subcategory) when cardiomyopathy is primary, idiopathic, or when no systemic cause has been identified or documented.
  • Do not default to I43 simply because a patient has both a systemic disease and cardiomyopathy. The physician must explicitly link them.

When documentation is ambiguous, query the physician before coding. Coding compliance depends on specificity. Practices using digital intake forms with structured fields for underlying systemic diagnoses create a natural audit trail that supports cleaner I43 vs. I42 coding decisions downstream.

Customizable consent and intake forms
Customizable consent and intake forms

Conclusion

Secondary cardiomyopathy coding hinges on one rule: the etiology always comes first. ICD-10 Code I43 is billable, valid, and specific – but it only functions correctly when the underlying systemic disease is coded and sequenced before it. Missed sequencing, absent causal language, and I42/I43 confusion are the three failure points that account for nearly all denial and audit risk in this code area.

Practices that embed etiology-first prompts into their clinical workflow catch these errors before claims leave the building. Pabau’s practice management tools for complex systemic disease specialties support structured documentation workflows that surface sequencing requirements automatically. To see how Pabau handles multi-code cardiology and chronic disease encounters, book a demo with the team.

Continue your research

Continue your research

Need ICD-10 coding guidance for other cardiovascular diagnoses? ICD-10 codes for cardiovascular emergencies covers sequencing rules and documentation requirements for acute vascular diagnoses alongside cardiac coding.

Looking to reduce coding errors across your clinic? Pabau’s claims management software supports multi-code sequencing for etiology-manifestation pairs, helping cardiology practices submit cleaner claims.

Want to streamline cardiology documentation workflows? EHR integration workflows explains how connecting clinical notes to billing modules catches sequencing errors before claim submission.

Frequently Asked Questions

What is ICD-10 Code I43?

ICD-10 Code I43 is a billable 2026 ICD-10-CM diagnosis code for cardiomyopathy in diseases classified elsewhere — heart muscle dysfunction arising as a direct manifestation of another systemic disease, not a primary cardiac condition. It sits within Chapter 9 (Diseases of the Circulatory System) under the I30-I5A subcategory.

Does I43 require a Code First instruction?

Yes. The underlying systemic disease must always be listed as the principal diagnosis before I43. Reversing this sequence is a coding error that triggers claim denials.

What is the ICD-9-CM equivalent of ICD-10 Code I43?

The approximate ICD-9-CM equivalent is 425.8 (Cardiomyopathy in other diseases classified elsewhere), confirmed in standard CMS conversion tables. The mapping is approximate — ICD-10-CM provides greater specificity than ICD-9 allowed.

When should I use I43 instead of I42?

Use I43 when the physician explicitly documents a named systemic disease causing the cardiomyopathy. Use I42 when cardiomyopathy is primary, idiopathic, or when no underlying systemic cause has been documented.

Are there valid subcategories under I43 in ICD-10-CM?

No. I43 is a flat code in U.S. ICD-10-CM with no valid subcategories. Report I43 only, without any extension, when coding for U.S. payers.

Can I43 be used without an underlying disease code?

No. I43 must always be accompanied by the underlying systemic disease code, which must appear before I43 in the diagnosis sequence. Using I43 alone violates the Code First instruction.

×